vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and SYPRIS SOLUTIONS INC (SYPR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $30.3M, roughly 1.0× SYPRIS SOLUTIONS INC). SYPRIS SOLUTIONS INC runs the higher net margin — -12.9% vs -32.1%, a 19.2% gap on every dollar of revenue. On growth, LIFECORE BIOMEDICAL, INC. \DE\ posted the faster year-over-year revenue change (-4.5% vs -9.5%). LIFECORE BIOMEDICAL, INC. \DE\ produced more free cash flow last quarter ($25.0K vs $-1.5M). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -7.7%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Sypris Solutions Inc. is a U.S.-headquartered provider of highly engineered components and specialized technical services, primarily serving aerospace, defense, automotive and commercial industrial markets. It delivers custom manufacturing, performance testing, and value-added engineering support for mission-critical systems and parts for global enterprise clients.
LFCR vs SYPR — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $30.3M |
| Net Profit | $-10.0M | $-3.9M |
| Gross Margin | 25.0% | 4.6% |
| Operating Margin | -9.9% | -10.9% |
| Net Margin | -32.1% | -12.9% |
| Revenue YoY | -4.5% | -9.5% |
| Net Profit YoY | -52.0% | -2992.6% |
| EPS (diluted) | $-0.29 | $-0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $30.3M | ||
| Q3 25 | $31.1M | $28.7M | ||
| Q2 25 | — | $31.4M | ||
| Q1 25 | $35.2M | $29.5M | ||
| Q4 24 | $32.6M | $33.4M | ||
| Q3 24 | $24.7M | $35.7M | ||
| Q2 24 | — | $35.5M | ||
| Q1 24 | $35.7M | $35.6M |
| Q4 25 | — | $-3.9M | ||
| Q3 25 | $-10.0M | $517.0K | ||
| Q2 25 | — | $-2.1M | ||
| Q1 25 | $-14.8M | $-899.0K | ||
| Q4 24 | $-6.6M | $135.0K | ||
| Q3 24 | $-16.2M | $390.0K | ||
| Q2 24 | — | $16.0K | ||
| Q1 24 | $15.6M | $-2.2M |
| Q4 25 | — | 4.6% | ||
| Q3 25 | 25.0% | 7.2% | ||
| Q2 25 | — | 8.2% | ||
| Q1 25 | 28.0% | 11.4% | ||
| Q4 24 | 34.0% | 16.1% | ||
| Q3 24 | 21.8% | 16.8% | ||
| Q2 24 | — | 15.9% | ||
| Q1 24 | 33.3% | 8.1% |
| Q4 25 | — | -10.9% | ||
| Q3 25 | -9.9% | -6.1% | ||
| Q2 25 | — | -4.6% | ||
| Q1 25 | -25.7% | -0.4% | ||
| Q4 24 | -6.0% | 3.9% | ||
| Q3 24 | -46.9% | 4.8% | ||
| Q2 24 | — | 3.6% | ||
| Q1 24 | -2.5% | -3.9% |
| Q4 25 | — | -12.9% | ||
| Q3 25 | -32.1% | 1.8% | ||
| Q2 25 | — | -6.5% | ||
| Q1 25 | -42.0% | -3.0% | ||
| Q4 24 | -20.2% | 0.4% | ||
| Q3 24 | -65.7% | 1.1% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | 43.8% | -6.2% |
| Q4 25 | — | $-0.17 | ||
| Q3 25 | $-0.29 | $0.02 | ||
| Q2 25 | — | $-0.09 | ||
| Q1 25 | $-0.47 | $-0.04 | ||
| Q4 24 | $-0.25 | $0.00 | ||
| Q3 24 | $-0.53 | $0.02 | ||
| Q2 24 | — | $0.00 | ||
| Q1 24 | $0.42 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | — |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $17.8M |
| Total Assets | $235.2M | $107.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $18.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $5.4M | — | ||
| Q4 24 | $9.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — |
| Q4 25 | — | $17.8M | ||
| Q3 25 | $-10.5M | $20.0M | ||
| Q2 25 | — | $18.7M | ||
| Q1 25 | $2.2M | $19.0M | ||
| Q4 24 | $15.4M | $19.6M | ||
| Q3 24 | $-3.9M | $18.2M | ||
| Q2 24 | — | $19.0M | ||
| Q1 24 | $17.7M | $20.8M |
| Q4 25 | — | $107.8M | ||
| Q3 25 | $235.2M | $112.5M | ||
| Q2 25 | — | $105.8M | ||
| Q1 25 | $237.7M | $110.2M | ||
| Q4 24 | $255.4M | $119.4M | ||
| Q3 24 | $246.8M | $121.6M | ||
| Q2 24 | — | $124.2M | ||
| Q1 24 | $246.2M | $129.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $-1.1M |
| Free Cash FlowOCF − Capex | $25.0K | $-1.5M |
| FCF MarginFCF / Revenue | 0.1% | -5.0% |
| Capex IntensityCapex / Revenue | 5.6% | 1.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $-6.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.1M | ||
| Q3 25 | $1.8M | $-178.0K | ||
| Q2 25 | — | $1.1M | ||
| Q1 25 | $1.2M | $-5.5M | ||
| Q4 24 | $-6.1M | $2.3M | ||
| Q3 24 | $-613.0K | $-4.8M | ||
| Q2 24 | — | $6.2M | ||
| Q1 24 | $-1.4M | $-1.7M |
| Q4 25 | — | $-1.5M | ||
| Q3 25 | $25.0K | $-390.0K | ||
| Q2 25 | — | $941.0K | ||
| Q1 25 | $-4.3M | $-5.5M | ||
| Q4 24 | $-8.6M | $1.9M | ||
| Q3 24 | $-4.0M | $-4.9M | ||
| Q2 24 | — | $6.0M | ||
| Q1 24 | $-7.8M | $-2.0M |
| Q4 25 | — | -5.0% | ||
| Q3 25 | 0.1% | -1.4% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | -12.1% | -18.8% | ||
| Q4 24 | -26.3% | 5.7% | ||
| Q3 24 | -16.3% | -13.8% | ||
| Q2 24 | — | 16.8% | ||
| Q1 24 | -21.8% | -5.7% |
| Q4 25 | — | 1.3% | ||
| Q3 25 | 5.6% | 0.7% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | 15.5% | 0.0% | ||
| Q4 24 | 7.5% | 1.2% | ||
| Q3 24 | 13.9% | 0.4% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | 17.8% | 0.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | -0.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 17.13× | ||
| Q3 24 | — | -12.21× | ||
| Q2 24 | — | 385.25× | ||
| Q1 24 | -0.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
SYPR
| Sypris Electronics | $17.7M | 59% |
| Transferred At Point In Time | $12.5M | 41% |
